Consider Using Auryxia to Bind Phosphate AND Increase Iron

August 2015

Auryxia (aw-RIK-see-uh, ferric citrate) is the first phosphate binder that also increases iron levels in chronic kidney disease patients.

It's an iron-based phosphate binder like Velphoro...but the iron in Auryxia is absorbed so it can help improve anemia.

Auryxia reduces IV iron needs by about 50%...and erythropoiesis-stimulating agents (Epogen, etc) by about 25%...over one year.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote